Clinical trial
An Efficacy Study of Benzalkonium Chloride Solution Clearing the Oral Colonized Bacterium in Hospitalized Patients With COPD
NCT02269800 is registered in ClinicalTrials.gov with Lustre Pharmaceutical Lab Co., Ltd as lead sponsor.
Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.
Registry record
As filed in ClinicalTrials.gov.
- Title
- An Efficacy Study of Benzalkonium Chloride Solution Clearing the Oral Colonized Bacterium in Hospitalized Patients With COPD
- Lead sponsor
- Lustre Pharmaceutical Lab Co., Ltd
- Phase
- Phase 4
- Overall status
- Unknown status
- Start date
- October 31, 2014
- Completion date
- July 31, 2015
- Enrollment
- 60 (estimated)
- Sites
- Not reported
Conditions
As the registry lists them; a condition with its own page is linked.
chronic obstructive pulmonary disease